Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page history shows a new site revision (v3.4.2) was added, and an old funding-notice and a previous revision (v3.4.1) were removed.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a government funding lapse was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedIntroduces a glossary toggle, color-coded change indicators for additions and deletions, and updated revision labels in the history view.SummaryDifference0.6%

- Check42 days agoChange DetectedThe record history now shows a new revision entry v3.3.4 and excludes the previous v3.3.3 entry. This is an administrative update to the version history and does not change trial data or status.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a new Study Status section with updates on 2025-12-24 and 2025-12-08, and deleted an entry on 2025-09-03.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded a new Revision: v3.3.3 to the Record History. Removed the HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.